Review



control mabs  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    R&D Systems control mabs
    Control Mabs, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+17b/us11773159-1732-3-13?v=R%26D+Systems
    Average 92 stars, based on 3 article reviews
    control mabs - by Bioz Stars, 2026-07
    92/100 stars

    Images



    Similar Products

    92
    R&D Systems control mabs
    Control Mabs, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+17b/us11773159-1732-3-13?v=R%26D+Systems
    Average 92 stars, based on 1 article reviews
    control mabs - by Bioz Stars, 2026-07
    92/100 stars
      Buy from Supplier

    90
    R&D Systems anti-human il-17b
    Anti Human Il 17b, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+17b/us10793628-830-6-11?v=R%26D+Systems
    Average 90 stars, based on 1 article reviews
    anti-human il-17b - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    92
    R&D Systems anti human il 17b
    Anti Human Il 17b, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+17b/us10793628-830-9-11?v=R%26D+Systems
    Average 92 stars, based on 1 article reviews
    anti human il 17b - by Bioz Stars, 2026-07
    92/100 stars
      Buy from Supplier

    88
    R&D Systems goat anti hu il 17b
    Goat Anti Hu Il 17b, supplied by R&D Systems, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+17b/us10683349-1481-23-25?v=R%26D+Systems
    Average 88 stars, based on 1 article reviews
    goat anti hu il 17b - by Bioz Stars, 2026-07
    88/100 stars
      Buy from Supplier

    90
    Novus Biologicals rabbit anti-human il-17b
    Rabbit Anti Human Il 17b, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+17b/pm29569854-70-6-12?v=Novus+Biologicals
    Average 90 stars, based on 1 article reviews
    rabbit anti-human il-17b - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Novus Biologicals rabbit anti human il 17b
    Rabbit Anti Human Il 17b, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+17b/pm29569854-70-9-12?v=Novus+Biologicals
    Average 90 stars, based on 1 article reviews
    rabbit anti human il 17b - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    R&D Systems il 17b af1248 goat igg pabs
    Figure 1 <t>|</t> <t>IL-17A,</t> <t>IL-17F,</t> CXCL8, and IL-1ra mRNA expression levels in human neutrophils activated by a variety of stimuli. Human neutrophils were cultured at 5 × 106/ml for up to 20 h with (A) 100 U/ml IFNγ and/or 100 ng/ml LPS; (B) 1,000 U/ml IFNα and/or 5 µM R848; (C) 10 ng/ml GM-CSF or 100 nM fMLF; (D) 1,000 U/ml G-CSF or 5 ng/ml TNFα. IL-17A, IL-17F, CXCL8, and IL-1ra mRNA expression was evaluated by reverse transcription quantitative real-time PCR (RT-qPCR) and data depicted as mean normalized expression (MNE) units after GAPDH mRNA normalization. The experiments depicted in each panels (A–D) are representative of at least three ones with similar results. Error bars stand for SEs calculated from triplicate qPCR reactions.
    Il 17b Af1248 Goat Igg Pabs, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+17b/pm29719541-70-16-22?v=R%26D+Systems
    Average 90 stars, based on 1 article reviews
    il 17b af1248 goat igg pabs - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    88
    R&D Systems anti human il 17a
    Lack of <t> IL-17A </t> and IL-17F production by activated human neutrophils.
    Anti Human Il 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+17b/pmc05913333-68-29-41?v=R%26D+Systems
    Average 88 stars, based on 1 article reviews
    anti human il 17a - by Bioz Stars, 2026-07
    88/100 stars
      Buy from Supplier

    Image Search Results


    Figure 1 | IL-17A, IL-17F, CXCL8, and IL-1ra mRNA expression levels in human neutrophils activated by a variety of stimuli. Human neutrophils were cultured at 5 × 106/ml for up to 20 h with (A) 100 U/ml IFNγ and/or 100 ng/ml LPS; (B) 1,000 U/ml IFNα and/or 5 µM R848; (C) 10 ng/ml GM-CSF or 100 nM fMLF; (D) 1,000 U/ml G-CSF or 5 ng/ml TNFα. IL-17A, IL-17F, CXCL8, and IL-1ra mRNA expression was evaluated by reverse transcription quantitative real-time PCR (RT-qPCR) and data depicted as mean normalized expression (MNE) units after GAPDH mRNA normalization. The experiments depicted in each panels (A–D) are representative of at least three ones with similar results. Error bars stand for SEs calculated from triplicate qPCR reactions.

    Journal: Frontiers in immunology

    Article Title: A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro : Failure to Reproducibly Detect It.

    doi: 10.3389/fimmu.2018.00795

    Figure Lengend Snippet: Figure 1 | IL-17A, IL-17F, CXCL8, and IL-1ra mRNA expression levels in human neutrophils activated by a variety of stimuli. Human neutrophils were cultured at 5 × 106/ml for up to 20 h with (A) 100 U/ml IFNγ and/or 100 ng/ml LPS; (B) 1,000 U/ml IFNα and/or 5 µM R848; (C) 10 ng/ml GM-CSF or 100 nM fMLF; (D) 1,000 U/ml G-CSF or 5 ng/ml TNFα. IL-17A, IL-17F, CXCL8, and IL-1ra mRNA expression was evaluated by reverse transcription quantitative real-time PCR (RT-qPCR) and data depicted as mean normalized expression (MNE) units after GAPDH mRNA normalization. The experiments depicted in each panels (A–D) are representative of at least three ones with similar results. Error bars stand for SEs calculated from triplicate qPCR reactions.

    Article Snippet: Protein-rich flow-through from neutrophils were then immunoblotted by standard procedures using the anti-human IL-17A (AF-317-NA) and IL-17B (AF1248) goat IgG pAbs from R&D Systems; anti-human phospho-STAT3 (Tyr705) rabbit pAbs (#9131, Cell Signaling, Beverly, MA, USA); anti-human STAT3 rabbit pAbs (sc-482, Santa Cruz Biotechnology, Dallas, TX, USA), and anti-human β-actin mAbs (A5060 from Sigma).

    Techniques: Expressing, Cell Culture, Reverse Transcription, Real-time Polymerase Chain Reaction, Quantitative RT-PCR

    Figure 2 | No induction of IL-17A, IL-17F, and IL-17RC mRNA expression in neutrophils incubated with IL-6 plus IL-23, in combination with inactivated Aspergillus fumigatus hyphae or conidia. Neutrophils (5 × 106/ml) were incubated either with 100 ng/ml rIL-17A for 2 h or with or without 20 µg/ml IL-6 plus 2 µg/ml IL-23 for 1 h, prior to adding, or not, inactivated A. fumigatus conidia (1:5 neutrophils/conidia ratio) and hyphae (1:1 neutrophils/hyphae ratio) for additional 1 h. Neutrophils were then harvested for RNA extraction to evaluate IL-17A (A), IL-17F (B), IL-17RC (C), IL-17RA (D), and SOCS3 (F) mRNA expression by reverse transcription quantitative real-time PCR. Gene expression data are depicted as mean normalized expression (MNE) units after GAPDH mRNA normalization (mean ± SEM, n = 4). Asterisks stand for significant differences as compared to untreated cells: *P < 0.05, **P < 0.01, by Student’s t-test. (E) Immunoblot displaying STAT3 tyrosine phosphorylation in neutrophils, either untreated or cultured for 15 or 60 min with 20 µg/ml IL-6 plus 2 µg/ml IL-23 (representative experiment, n = 2).

    Journal: Frontiers in immunology

    Article Title: A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro : Failure to Reproducibly Detect It.

    doi: 10.3389/fimmu.2018.00795

    Figure Lengend Snippet: Figure 2 | No induction of IL-17A, IL-17F, and IL-17RC mRNA expression in neutrophils incubated with IL-6 plus IL-23, in combination with inactivated Aspergillus fumigatus hyphae or conidia. Neutrophils (5 × 106/ml) were incubated either with 100 ng/ml rIL-17A for 2 h or with or without 20 µg/ml IL-6 plus 2 µg/ml IL-23 for 1 h, prior to adding, or not, inactivated A. fumigatus conidia (1:5 neutrophils/conidia ratio) and hyphae (1:1 neutrophils/hyphae ratio) for additional 1 h. Neutrophils were then harvested for RNA extraction to evaluate IL-17A (A), IL-17F (B), IL-17RC (C), IL-17RA (D), and SOCS3 (F) mRNA expression by reverse transcription quantitative real-time PCR. Gene expression data are depicted as mean normalized expression (MNE) units after GAPDH mRNA normalization (mean ± SEM, n = 4). Asterisks stand for significant differences as compared to untreated cells: *P < 0.05, **P < 0.01, by Student’s t-test. (E) Immunoblot displaying STAT3 tyrosine phosphorylation in neutrophils, either untreated or cultured for 15 or 60 min with 20 µg/ml IL-6 plus 2 µg/ml IL-23 (representative experiment, n = 2).

    Article Snippet: Protein-rich flow-through from neutrophils were then immunoblotted by standard procedures using the anti-human IL-17A (AF-317-NA) and IL-17B (AF1248) goat IgG pAbs from R&D Systems; anti-human phospho-STAT3 (Tyr705) rabbit pAbs (#9131, Cell Signaling, Beverly, MA, USA); anti-human STAT3 rabbit pAbs (sc-482, Santa Cruz Biotechnology, Dallas, TX, USA), and anti-human β-actin mAbs (A5060 from Sigma).

    Techniques: Expressing, Incubation, RNA Extraction, Reverse Transcription, Real-time Polymerase Chain Reaction, Gene Expression, Western Blot, Phospho-proteomics, Cell Culture

    Figure 3 | Lack of IL-17A and IL-17F production by human neutrophils activated by IL-6 plus IL-23 in combination with inactivated Aspergillus fumigatus hyphae or conidia. Neutrophils (5 × 106/ml) were incubated with or without 20 µg/ml IL-6 plus 2 µg/ml IL-23 and then cultured for three more hours in the presence or not of inactivated A. fumigatus conidia and hyphae (used at 1:5 and 1:1, respectively). After incubation, IL-17A (A) and CXCL8 (B) levels were determined in cell-free supernatants and in corresponding cell pellets by specific ELISA. Values are depicted as the mean ± SD or as not detected (nd) when values were under the detection limit (n = 3). Asterisks stand for significant differences as compared to untreated cells: *P < 0.05, **P < 0.01, by Student’s t-test.

    Journal: Frontiers in immunology

    Article Title: A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro : Failure to Reproducibly Detect It.

    doi: 10.3389/fimmu.2018.00795

    Figure Lengend Snippet: Figure 3 | Lack of IL-17A and IL-17F production by human neutrophils activated by IL-6 plus IL-23 in combination with inactivated Aspergillus fumigatus hyphae or conidia. Neutrophils (5 × 106/ml) were incubated with or without 20 µg/ml IL-6 plus 2 µg/ml IL-23 and then cultured for three more hours in the presence or not of inactivated A. fumigatus conidia and hyphae (used at 1:5 and 1:1, respectively). After incubation, IL-17A (A) and CXCL8 (B) levels were determined in cell-free supernatants and in corresponding cell pellets by specific ELISA. Values are depicted as the mean ± SD or as not detected (nd) when values were under the detection limit (n = 3). Asterisks stand for significant differences as compared to untreated cells: *P < 0.05, **P < 0.01, by Student’s t-test.

    Article Snippet: Protein-rich flow-through from neutrophils were then immunoblotted by standard procedures using the anti-human IL-17A (AF-317-NA) and IL-17B (AF1248) goat IgG pAbs from R&D Systems; anti-human phospho-STAT3 (Tyr705) rabbit pAbs (#9131, Cell Signaling, Beverly, MA, USA); anti-human STAT3 rabbit pAbs (sc-482, Santa Cruz Biotechnology, Dallas, TX, USA), and anti-human β-actin mAbs (A5060 from Sigma).

    Techniques: Incubation, Cell Culture, Enzyme-linked Immunosorbent Assay

    Figure 7 | IL-17A, IL-17F, IL-17RA, IL-17RC, CXCL8, TNFα, and SOCS3 mRNA expression, as well as IL-17R surface expression, in neutrophils from patients with psoriasis. (A) Neutrophils isolated from healthy donors (HDs) (n = 3) or psoriatic patients (n = 3) were cultured for 20 h with 100 U/ml IFNγ plus 100 ng/ml LPS, 5 µM R848, or 500 ng/ml IL-17A to evaluate IL-17A, IL-17F, IL-17RA, IL-17RC, CXCL8, TNFα, and SOCS3 mRNA expression by reverse transcription quantitative real-time PCR. Gene expression data are depicted as mean normalized expression (MNE) units after GAPDH mRNA normalization. (B) Surface IL-17RA and IL-17RC expression evaluated by flow cytometry in human neutrophils from HDs or psoriatic patients. Values represent the mean ± SEM (n = 3). For the data of panels (A,B) no significant differences between HDs or psoriatic patients were observed by two-way ANOVA followed by Bonferroni’s post-test.

    Journal: Frontiers in immunology

    Article Title: A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro : Failure to Reproducibly Detect It.

    doi: 10.3389/fimmu.2018.00795

    Figure Lengend Snippet: Figure 7 | IL-17A, IL-17F, IL-17RA, IL-17RC, CXCL8, TNFα, and SOCS3 mRNA expression, as well as IL-17R surface expression, in neutrophils from patients with psoriasis. (A) Neutrophils isolated from healthy donors (HDs) (n = 3) or psoriatic patients (n = 3) were cultured for 20 h with 100 U/ml IFNγ plus 100 ng/ml LPS, 5 µM R848, or 500 ng/ml IL-17A to evaluate IL-17A, IL-17F, IL-17RA, IL-17RC, CXCL8, TNFα, and SOCS3 mRNA expression by reverse transcription quantitative real-time PCR. Gene expression data are depicted as mean normalized expression (MNE) units after GAPDH mRNA normalization. (B) Surface IL-17RA and IL-17RC expression evaluated by flow cytometry in human neutrophils from HDs or psoriatic patients. Values represent the mean ± SEM (n = 3). For the data of panels (A,B) no significant differences between HDs or psoriatic patients were observed by two-way ANOVA followed by Bonferroni’s post-test.

    Article Snippet: Protein-rich flow-through from neutrophils were then immunoblotted by standard procedures using the anti-human IL-17A (AF-317-NA) and IL-17B (AF1248) goat IgG pAbs from R&D Systems; anti-human phospho-STAT3 (Tyr705) rabbit pAbs (#9131, Cell Signaling, Beverly, MA, USA); anti-human STAT3 rabbit pAbs (sc-482, Santa Cruz Biotechnology, Dallas, TX, USA), and anti-human β-actin mAbs (A5060 from Sigma).

    Techniques: Expressing, Isolation, Cell Culture, Reverse Transcription, Real-time Polymerase Chain Reaction, Gene Expression, Flow Cytometry

    Figure 8 | Staining human neutrophils by anti-IL-17A (AF-317-NA) polyclonal antibodies (Abs). (A) Immunofluorescence (top panels) and immunohistochemistry (lower panels) stainings of two FFPE cases of human pustular psoriasis using anti-IL-17A (AF-317-NA) and anti-CD66b Abs (as labeled). Top panels show DAPI, FITC channel, and merge to recognize neutrophil shape; lower panels show different magnification of IHC and double IHC to characterize IL-17A+ cells with the neutrophil marker CD66b. (B) Cytospins of neutrophils, either untreated (top panels) or treated with 5 µM R848 (bottom panels) for 3 h, were stained with anti-IL-17A (AF-317-NA, left panels) and anti-CXCL8 (right panels) Abs. Original magnification 200× [first row in (A) and left image in third row, scale bar 100 µm] and 400× [second row in (A), center/right images in third row in (A), as well as in (B), scale bar 50 µm]. Images of the second row in (A) represent magnifications of images in first row. (C) AF-317-NA immunoblot of lysates from neutrophils either freshly isolated (T0, from two donors) or incubated for 3 h with or without 2 µg/ml IL-6 plus 0.2 µg/ml IL-23 (low), 20 µg/ml IL-6 plus 2 µg/ml IL-23 (high), or 5 µM R848. Recombinant human IL-17A (rhIL-17A) was used as positive control. Panels (B,C) display representative experiments out of two independent ones with similar results.

    Journal: Frontiers in immunology

    Article Title: A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro : Failure to Reproducibly Detect It.

    doi: 10.3389/fimmu.2018.00795

    Figure Lengend Snippet: Figure 8 | Staining human neutrophils by anti-IL-17A (AF-317-NA) polyclonal antibodies (Abs). (A) Immunofluorescence (top panels) and immunohistochemistry (lower panels) stainings of two FFPE cases of human pustular psoriasis using anti-IL-17A (AF-317-NA) and anti-CD66b Abs (as labeled). Top panels show DAPI, FITC channel, and merge to recognize neutrophil shape; lower panels show different magnification of IHC and double IHC to characterize IL-17A+ cells with the neutrophil marker CD66b. (B) Cytospins of neutrophils, either untreated (top panels) or treated with 5 µM R848 (bottom panels) for 3 h, were stained with anti-IL-17A (AF-317-NA, left panels) and anti-CXCL8 (right panels) Abs. Original magnification 200× [first row in (A) and left image in third row, scale bar 100 µm] and 400× [second row in (A), center/right images in third row in (A), as well as in (B), scale bar 50 µm]. Images of the second row in (A) represent magnifications of images in first row. (C) AF-317-NA immunoblot of lysates from neutrophils either freshly isolated (T0, from two donors) or incubated for 3 h with or without 2 µg/ml IL-6 plus 0.2 µg/ml IL-23 (low), 20 µg/ml IL-6 plus 2 µg/ml IL-23 (high), or 5 µM R848. Recombinant human IL-17A (rhIL-17A) was used as positive control. Panels (B,C) display representative experiments out of two independent ones with similar results.

    Article Snippet: Protein-rich flow-through from neutrophils were then immunoblotted by standard procedures using the anti-human IL-17A (AF-317-NA) and IL-17B (AF1248) goat IgG pAbs from R&D Systems; anti-human phospho-STAT3 (Tyr705) rabbit pAbs (#9131, Cell Signaling, Beverly, MA, USA); anti-human STAT3 rabbit pAbs (sc-482, Santa Cruz Biotechnology, Dallas, TX, USA), and anti-human β-actin mAbs (A5060 from Sigma).

    Techniques: Staining, Immunofluorescence, Immunohistochemistry, Labeling, Marker, Western Blot, Isolation, Incubation, Recombinant, Positive Control

    Figure 9 | Levels of IL-17A, IL-17B, IL-17F, IL-10, IL-17RC, IL-17RA, azurocidin, neutrophil elastase, and myeloperoxidase (MPO) mRNA expression in neutrophils at different stages of maturation. mRNA expression data derive from Gene Expression Omnibus database (accession number GSE42519) (65). (A) IL-17A, IL-17B, IL-17F, IL-10, IL-17RC, and IL-17RA or (B) azurocidin (AZU1), neutrophil elastase (ELANE), and MPO mRNA expression levels were measured in the following cell types: hematopoietic stem cells (HSCs), multipotent progenitors (MPPs), common myeloid progenitors (CMPs), granulocyte-macrophage progenitors (GMPs), early and late promyelocytes (PMs), myelocytes (MYs), metamyelocytes (MMs), band cells (BCs), and bone marrow polymorphonuclear neutrophil granulocytes. Values represent the mean ± SEM as calculated from data of the biological replicates present in the database.

    Journal: Frontiers in immunology

    Article Title: A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro : Failure to Reproducibly Detect It.

    doi: 10.3389/fimmu.2018.00795

    Figure Lengend Snippet: Figure 9 | Levels of IL-17A, IL-17B, IL-17F, IL-10, IL-17RC, IL-17RA, azurocidin, neutrophil elastase, and myeloperoxidase (MPO) mRNA expression in neutrophils at different stages of maturation. mRNA expression data derive from Gene Expression Omnibus database (accession number GSE42519) (65). (A) IL-17A, IL-17B, IL-17F, IL-10, IL-17RC, and IL-17RA or (B) azurocidin (AZU1), neutrophil elastase (ELANE), and MPO mRNA expression levels were measured in the following cell types: hematopoietic stem cells (HSCs), multipotent progenitors (MPPs), common myeloid progenitors (CMPs), granulocyte-macrophage progenitors (GMPs), early and late promyelocytes (PMs), myelocytes (MYs), metamyelocytes (MMs), band cells (BCs), and bone marrow polymorphonuclear neutrophil granulocytes. Values represent the mean ± SEM as calculated from data of the biological replicates present in the database.

    Article Snippet: Protein-rich flow-through from neutrophils were then immunoblotted by standard procedures using the anti-human IL-17A (AF-317-NA) and IL-17B (AF1248) goat IgG pAbs from R&D Systems; anti-human phospho-STAT3 (Tyr705) rabbit pAbs (#9131, Cell Signaling, Beverly, MA, USA); anti-human STAT3 rabbit pAbs (sc-482, Santa Cruz Biotechnology, Dallas, TX, USA), and anti-human β-actin mAbs (A5060 from Sigma).

    Techniques: Expressing, Gene Expression

    Figure 10 | Staining human neutrophils by anti-IL-17B (AF1248) antibodies (Abs). (A) Immunofluorescence (top panels) and immunohistochemistry (lower panels) staining of two FFPE cases of human pustular psoriasis using anti-IL-17B (AF1248) and CD66b Abs (as labeled). Top panels show DAPI, FITC channel, and merge to recognize neutrophil shape; lower panels show different magnification of IHC and double IHC to characterize IL-17A+ cells with the neutrophil marker CD66b. (B) Cytospins of neutrophils incubated without (top panel) or with 5 µM R848 (bottom panel) for 3 h. Original magnification 200× [first row in (A) and left image in third row, scale bar 100 µm] and 400× [second row in (A), center/right images in third row in (A), as well as in (B), scale bar 50 µm]. Images of the second row in (A) represent magnifications of images in first row. (C) AF1248 immunoblot of lysates from neutrophils either freshly isolated (T0, from two donors) or incubated for 3 h with or without 2 µg/ml IL-6 plus 0.2 µg/ml IL-23 (low), 20 µg/ml IL-6 plus 2 µg/ml IL-23 (high), or 5 µM R848. Recombinant human IL-17B (rhIL-17B) was used as positive control. Panels (B,C) display representative experiments out of two independent ones with similar results.

    Journal: Frontiers in immunology

    Article Title: A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro : Failure to Reproducibly Detect It.

    doi: 10.3389/fimmu.2018.00795

    Figure Lengend Snippet: Figure 10 | Staining human neutrophils by anti-IL-17B (AF1248) antibodies (Abs). (A) Immunofluorescence (top panels) and immunohistochemistry (lower panels) staining of two FFPE cases of human pustular psoriasis using anti-IL-17B (AF1248) and CD66b Abs (as labeled). Top panels show DAPI, FITC channel, and merge to recognize neutrophil shape; lower panels show different magnification of IHC and double IHC to characterize IL-17A+ cells with the neutrophil marker CD66b. (B) Cytospins of neutrophils incubated without (top panel) or with 5 µM R848 (bottom panel) for 3 h. Original magnification 200× [first row in (A) and left image in third row, scale bar 100 µm] and 400× [second row in (A), center/right images in third row in (A), as well as in (B), scale bar 50 µm]. Images of the second row in (A) represent magnifications of images in first row. (C) AF1248 immunoblot of lysates from neutrophils either freshly isolated (T0, from two donors) or incubated for 3 h with or without 2 µg/ml IL-6 plus 0.2 µg/ml IL-23 (low), 20 µg/ml IL-6 plus 2 µg/ml IL-23 (high), or 5 µM R848. Recombinant human IL-17B (rhIL-17B) was used as positive control. Panels (B,C) display representative experiments out of two independent ones with similar results.

    Article Snippet: Protein-rich flow-through from neutrophils were then immunoblotted by standard procedures using the anti-human IL-17A (AF-317-NA) and IL-17B (AF1248) goat IgG pAbs from R&D Systems; anti-human phospho-STAT3 (Tyr705) rabbit pAbs (#9131, Cell Signaling, Beverly, MA, USA); anti-human STAT3 rabbit pAbs (sc-482, Santa Cruz Biotechnology, Dallas, TX, USA), and anti-human β-actin mAbs (A5060 from Sigma).

    Techniques: Staining, Immunofluorescence, Immunohistochemistry, Labeling, Marker, Incubation, Western Blot, Isolation, Recombinant, Positive Control

    Lack of  IL-17A  and IL-17F production by activated human neutrophils.

    Journal: Frontiers in Immunology

    Article Title: A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro : Failure to Reproducibly Detect It

    doi: 10.3389/fimmu.2018.00795

    Figure Lengend Snippet: Lack of IL-17A and IL-17F production by activated human neutrophils.

    Article Snippet: After coverslip removal, specimens were rehydrated through a scale of alcohols, with endogenous peroxidase activity blocked by treatment with 0.3% H 2 O 2 in methanol for 20 min. Anti-human IL-17A (AF-317-NA), IL-17B (AF1248), and CXCL8 (AF-208) goat IgG pAbs from R&D Systems were 1:50 diluted, added to specimens for 60 min and then revealed using the goat-on-Rodent HRP-polymer (Biocare Medical, Pacheco, CA, USA) followed by diaminobenzidine.

    Techniques: